TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $50.83M2016: $68.37M2017: $78.16M2018: $29.85M2019: $57.91M2020: $109.92M2021: $263.58M2022: $247.04M2023: $243.10M2024: $234.11M$234.11M
2015Total Liabilities (USD)2024
Fiscal YearTotal LiabilitiesChange YoY
2024$234.11M-3.7%
2023$243.10M-1.6%
2022$247.04M-6.3%
2021$263.58M+139.8%
2020$109.92M+89.8%
2019$57.91M+94.0%
2018$29.85M-61.8%
2017$78.16M+14.3%
2016$68.37M+34.5%
2015$50.83M—